Found 37 matching trials
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 PHASE2 The primary objective of this study is to evaluate the safety and efficacy ...
Show More Location
UCI Center for Clinical Research
Learn More & Join Trial
BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP. PHASE3 Multicenter randomized double blind study versus placebo during 12 weeks wi...
Show More Location
Centre Hospitalier Universitaire de Grenoble
Learn More & Join Trial
Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV) PHASE3 This is a multicentric international phase III, double blind randomized stu...
Show More Learn More & Join Trial
A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment PHASE2 * The study primary end point is the decrease in the number of monthly heav...
Show More Location
Multiple Locations
Learn More & Join Trial
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers PHASE1 This is a double-blind, randomized, placebo-controlled, crossover design tr...
Show More Location
Boston University Psychiatry Research Center, Clinical Studies Unit
Learn More & Join Trial
Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents PHASE2 Proof of concept, multicenter, randomized, double-blind, placebo-controlled...
Show More Status
Active Not Recruiting
Location
Centre Hospitalier Charles Perrens
Learn More & Join Trial
A Study of Pitolisant in Patients With Prader-Willi Syndrome PHASE3 This is a Phase 3, randomized, double-blind, placebo-controlled, multicente...
Show More Location
Santa Monica Clinical Trials
Learn More & Join Trial
Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant) PHASE3 This is a multicentric International Phase III,Long term open label study(1...
Show More Learn More & Join Trial
Pitolisant in Refractory Restless Legs Syndrome PHASE4 This is an open-label trial in Restless Legs Syndrome (RLS) patients inadeq...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness PHASE3 The first objective of this study is to demonstrate the efficacy and safety...
Show More Location
Laboratoire du sommeil Clinique de Physiologie, Sommeil et Exercice Pôle Thorax et Vaisseaux CHU de Grenoble
Learn More & Join Trial